Artificial Intelligence in Healthcare Diagnosis PPT
                     Artificial Intelligence in Healthcare Diagnosis
 
Artificial Intelligence in Healthcare 
Diagnosis Market Forecast to 2027 - 
COVID-19 Impact and Global Analysis 
By Diagnostic Tool (Medical Imaging 
Tool, Automated Detection System, 
and Others); Application (Eye Care, 
Oncology, Radiology, Cardiovascular, 
and Others); End User (Hospital and 
Clinic, Diagnostic Laboratory, and 
Home Care); Service (Tele-
Consultation, Tele Monitoring, and 
Others); and Geography
Hemophilia Treatment Market 
Current and future Market Scenario
 According to the latest study on “Artificial Intelligence in Healthcare Diagnosis Market Forecast to 2027 - 
COVID-19 Impact and Global Analysis Diagnostic Tool, Application, Service, and End User,” the market 
was valued at US$ 3,639.02 million in 2019 and is projected to reach US$  66,811.97 million by 2027; it is 
expected to grow at a CAGR of 44.0% during 2020–2027. 
  The report highlights the trends prevailing in the global artificial intelligence in healthcare diagnosis 
market, and drivers and deterrents pertaining to the market growth.
 Based on diagnostic tool, the artificial intelligence in healthcare diagnosis market is segmented into medical 
imaging tool, automated detection system, and others. In 2019, the medical imaging tool segment 
accounted for the largest share of the market. The growth of the segmental market is attributed to the 
rising number of FDA approvals for the AI-based medical imaging tools. 
 Factors such as the rising adoption of artificial intelligence in disease identification and diagnosis 
and increasing investments in AI healthcare startups are driving the growth of the AI in healthcare diagnosis 
market. However, the lack of skilled workforce and ambiguity of regulatory guidelines for medical 
software impede the market growth. Further, the increasing potential in emerging economies offers 
significant opportunities for the future growth of the global artificial intelligence in healthcare diagnosis 
market players.
Key Findings
 Market Insights
 
 Increasing Investment in AI Healthcare Startups Drives Market Growth
Artificial Intelligence in healthcare is one of the most significant technological advances in medicine thus far. 
Startups developing AI-driven imaging & diagnostic solutions are the major factors responsible for the growth 
of the market in the study period. China, the US, and the UK are emerging as a popular hub for healthcare 
innovations. China-based healthcare AI startups have benefited from the government’s AI-focused 
development strategy, inspiring investment, and private-public partnerships. Additionally, the British 
government has announced a National Artificial Intelligence Lab that will collaborate with Britain’s 
universities and technology companies to research on cancer, dementia, and heart disease. UK-based 
startups have benefited from the government’s robust library of patient data, as British citizen’s share their 
anonymous healthcare data with the British National Health Service.
Hemophilia Treatment Market 
 
Market Segments
By Diagnostic Tool  
Medical Imaging Tool
Automated Detection System By Application By End User
Others Eye Care Hospitals and Clinics
Oncology Diagnostic Laboratory
Radiology Home Care
Cardiovascular Doctors
Others Patients
Hemophilia Treatment Market 
Dominating Segments
 
 End User Insights
 
 Based on end user, the global artificial intelligence in healthcare diagnosis market is segmented into hospital 
and clinic, diagnostic laboratory, and home care. The hospital and clinic segment held the largest share of 
the market in 2019, and the segment is expected to register the highest CAGR in the market during the 
forecast period. The adoption of AI has increases in hospitals with the rise in the prevalence of chronic 
diseases such as cancer and rare diseases as the technology assist in providing better treatments, especially 
to newborns with complex disorders. In 2018, ~9.6 million people died due to cancer worldwide. With the 
analysis of over 1.7 million new cancer cases and more than 606,000 expected cancer deaths in 2019, 
advancements in cancer diagnostic methods and medication options are need of the time. Advanced AI are 
capable of drastically altering cancer diagnosis landscape and treated through machine  learning to 
distinguish imagery of tissue containing cancerous cells from pictures of healthy tissue such advantages 
offered by AI will further increase the adoption in the hospitals and clinics.
  
Dominating Segments
 Product Insights
 Strategic Insights
 Collaborations and technology partnerships by the players in the artificial intelligence in healthcare diagnosis 
market to bridge the demand-supply gap are anticipated to play a significant role in the growth of the market 
during the forecast period.
 Download PDF Brochure https://www.theinsightpartners.com/sample/TIPRE00011852/
Dominating Segments
 The report segments the global artificial intelligence in healthcare diagnosis market as follows: 
 By Diagnostic Tool
 Medical Imaging Tool
 Automated Detection System
 Others

By Application
 Eye Care
 Oncology
 Radiology
 Cardiovascular
 Others
Dominating Segments
 By Service
 Tele-Consultation
 Tele Monitoring
 Others

By End User
 Hospitals and Clinics
 Diagnostic Laboratory
 Home Care
 Doctors
 Patients
Hemophilia Treatment Market  
Leading Players
 Company Profiles
General Electric Company
Aidoc
Arterys Inc.
Icometrix
IDx Technologies Inc
MaxQ AI Ltd.
Caption Health, Inc.
Zebra Medical Vision Inc.
Siemens Healthineers AG
Koninklijke Philips N.V
  REGIONAL FRAMEWORK
REGIONAL FRAMEWORK
  Hemophilia Treatment Market  
 
 
 Hemophilia Treatment Market 
 
 
        
Access Full Research Report at: 
https://www.theinsightpartners.com/reports/artificial-intelligence-in-healthcare-diagnos
is-market/
Thank You! 
 Thank You!